Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for DarioHealth Corp. (DRIO : NSDQ)

• Company Description    DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors and healthcare systems. DarioHealth Corp., formerly known as LabStyle Innovations Corp., is based in Ramat Gan, Israel. Number of Employees: 214

• Price / Volume Information    Yesterday's Closing Price: $6.19 Daily Weekly Monthly 20 Day Moving Average: 331,487 shares Shares Outstanding: 21.99 (millions) Market Capitalization: $136.10 (millions) Beta: 1.36 52 Week High: $23.80 52 Week Low: $4.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.92% 18.15% 12 Week -15.21% -6.79% Year To Date -52.27% -39.99%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 18 W. 18th St. - New York,NY 10011 USA ph: 972-4770-6377 fax: 972-4770-4059 ir@mydario.com http://www.mydario.com

• General Corporate Information    Officers Erez Raphael - Chief Executive Officer Yoav Shaked - Chairman Zvi Ben David - Chief Financial Officer Dennis Matheis - Director Hila Karah - Director Peer Information DarioHealth Corp. (ABMD) DarioHealth Corp. (DMDS) DarioHealth Corp. (CPWY.) DarioHealth Corp. (EQUR) DarioHealth Corp. (ECIA) DarioHealth Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 23725P209 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/15/22 Share - Related Items Shares Outstanding: 21.99 Most Recent Split Date: 11.00 (0.05:1) Beta: 1.36 Market Capitalization: $136.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.82 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.17 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/15/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.19 Price/Cash Flow: - Price / Sales: 5.45 EPS Growth vs. Year Ago Period: 19.57% vs. Previous Quarter: 32.11% Sales Growth vs. Year Ago Period: 124.17% vs. Previous Quarter: 33.69% ROE 03/31/22 - -73.61 12/31/21 - -73.04 09/30/21 - -71.45 ROA 03/31/22 - -65.27 12/31/21 - -64.90 09/30/21 - -63.60 Current Ratio 03/31/22 - 5.45 12/31/21 - 3.17 09/30/21 - 4.67 Quick Ratio 03/31/22 - 4.86 12/31/21 - 2.74 09/30/21 - 4.35 Operating Margin 03/31/22 - -311.13 12/31/21 - -374.21 09/30/21 - -391.42 Net Margin 03/31/22 - -311.13 12/31/21 - -374.21 09/30/21 - -391.42 Pre-Tax Margin 03/31/22 - -311.00 12/31/21 - -374.05 09/30/21 - -387.39 Book Value 03/31/22 - 5.19 12/31/21 - 5.16 09/30/21 - 6.31 Inventory Turnover 03/31/22 - 3.20 12/31/21 - 3.33 09/30/21 - 3.16 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©